Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves fine-tuning various variables, including cell line development, media composition, and bioreactor settings. A key goal is to amplify antibody production while minimizing production f